Mirtazapine-associated hyponatremia in an elderly patient

Annals of Pharmacotherapy

Volumn 43, Issue 6, 2009, Pages 1144-1145

  Famularo, Giuseppe ^a   Gasbarrone, Laura ^a   De Virgilio, Armando ^b   Minisola, Giovanni ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCHLOROTHIAZIDE; ISOTONIC SOLUTION; MIRTAZAPINE; SODIUM; SODIUM CHLORIDE; TELMISARTAN;

AGED; AGED HOSPITAL PATIENT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEPRESSION; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERTENSION; HYPONATREMIA; LETTER; NEUROLOGIC EXAMINATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SODIUM BLOOD LEVEL;

AGED; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSION; FEMALE; HUMANS; HYPERTENSION; HYPONATREMIA; MIANSERIN; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 67249160567     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L724     Document Type: Letter

References (5)

1. Gartlehner G, Gaynes BN, Hansen RA, et al. Comparative benefits and harms of second-generation of antidepressants: background paper for the American College of Physicians. Ann Intern Med 2008;149:734-750
2. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-245
3. Anttila SA, Leinonen EV. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev 2001;7:249-264 (Pubitemid 34016084)
4. Cheah CY, Ladhams B, Fegan PG. Mirtazapine associated with profound hyponatremia: two case reports. Am J Geriatr Pharmacother 2008;6:91-95
5. Spina E, Santoro V, D'Arrigo C. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. Clin Ther 2008;30:1206-1227